UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center

Photodermatology Photoimmunology and Photomedicine

Volumn 21, Issue 2, 2005, Pages 93-96

  Polderman, Marloes C A ^a   Wintzen, Marjolein ^b   le Cessie, Saskia ^a   Pavel, Stan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atopic dermatitis; Eczema; Treatment; UVA 1

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRYOTHERAPY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OPEN STUDY; PHOTOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; AGED; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIATION DOSAGE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 15844410582     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2005.00150.x     Document Type: Article

References (26)

1. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schopf E. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-230.
2. von Kobyletzki G, Freitag M, Herde M, et al. Phototherapy in severe atopic dermatitis. Comparison between current UVA1 therapy, UVA1 cold light and combined UVA-UVB therapy. Hautarzt 1999; 50: 27-33.
3. Grabbe J, Welker P, Humke S, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE- binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996; 107: 419-422.
4. Krutmann J, Diepgen TL, Luger TA, et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998; 38: 589-593.
5. Tzaneva S, Seeber A, Schwaiger M, Honigsmann H, Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001; 45: 503-507.
6. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
7. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
8. Asawanonda P, Ortel B, Taylor CR. Temperatures reached inside stand-up ultraviolet treatment boxes. Photodermatol Photoimmunol Photomed 1999; 15: 179-182.
9. Kowalzick L, Kleinheinz A, Weichenthal M, et al. Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm-Venereol 1995; 75: 43-45.
10. Dittmar HC, Pflieger D, Schopf E, Simon JC. UVA1 phototherapy. Pilot study of dose finding in acute exacerbated atopic dermatitis. Hautarzt 2001; 52: 423-427.
11. Abeck D, Schmidt T, Fesq H, et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000; 42: 254-257.
12. Krutmann J. Phototherapy for atopic dermatitis. Dermatol Therapy 1996; 1: 24-31.
13. Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 1990; 322: 1093-1097.
14. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study. J Invest Dermatol 2003; 121: 252-258.
15. de Gruijl FR, Sterenborg HJ, Forbes PD, et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res 1993; 53: 53-60.
16. de Laat A, van der Leun JC, de Gruijl FR. Carcinogenesis induced by UVA (365-nm) radiation: the dose-time dependence of tumor formation in hairless mice. Carcinogenesis 1997; 18: 1013-1020.
17. Sterenborg HJ, van der Leun JC. Tumorigenesis by a long wavelength UV-A source. Photochem Photobiol 1990; 51: 325-330.
18. Burren R, Scaletta C, Frenk E, Panizzon RG, Applegate LA. Sunlight and carcinogenesis: expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I+II and solar simulating radiations. Int J Cancer 1998; 76: 201-206.
19. Ley RD, Fourtanier A. UVAI-induced edema and pyrimidine dimers in murine skin. Photochem Photobiol 2000; 72: 485-487.
20. Seite S, Moyal D, Verdier MP, Hourseau C, Fourtanier A. Accumulated p53 protein and UVA protection level of sunscreens. Photodermatol Photoimmunol Photomed 2000; 16: 3-9.
21. De Fabo EC, Noonan FP, Fears T, Merlino G. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 2004; 64: 6372-6376.
22. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999; 112: 3-12.
23. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763-1768.
24. Godar DE, Lucas AD. Spectral dependence of UV-induced immediate and delayed apoptosis: the role of membrane and DNA damage. Photochem Photobiol 1995; 62: 108-113.
25. Vowels BR, Yoo EK, Gasparro FP. Kinetic analysis of apoptosis induction in human cell lines by UVA and 8-MOP. Photochem Photobiol 1996; 63: 572-576.
26. Breuckmann F, von Kobyletzki G, Avermaete A, et al. Mechanisms of apoptosis: UVA1-induced immediate and UVB-induced delayed apoptosis in human T cells in vitro. J Eur Acad Dermatol Venereol 2003; 17: 418-429.